[Construction and expression of Runx1-shRNA expressiong plasmid]

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Expression Regulation

Background:

• Runx1 is a crucial transcription factor involved in various cellular processes.
• Dysregulation of Runx1 has been implicated in the development of several cancers, including pulmonary adenocarcinoma.
• Targeting Runx1 offers a potential therapeutic strategy for lung cancer treatment.

Purpose of the Study:

• To construct a plasmid expressing short hairpin RNA (shRNA) targeting human Runx1.
• To evaluate the efficacy of the constructed plasmid in inhibiting Runx1 gene expression in human pulmonary adenocarcinoma cells (A549).

Main Methods:

• Design and synthesis of a human Runx1-specific shRNA sequence.
• Insertion of the shRNA into the pSuper plasmid via DNA recombination.
• Confirmation of the recombinant plasmid using PCR, enzyme digestion, and DNA sequencing.
• Transfection of A549 cells with the pSuper-Runx1-shRNA plasmid.
• Quantification of Runx1 mRNA and protein levels using real-time PCR and Western blot.

Main Results:

• The pSuper-Runx1-shRNA plasmid was successfully constructed and confirmed.
• Transfection with the plasmid led to significant inhibition of Runx1 expression in A549 cells.
• Real-time PCR showed a 33% reduction in Runx1 mRNA levels.
• Western blot analysis revealed a 50% decrease in Runx1 protein levels.

Conclusions:

• The constructed pSuper-Runx1-shRNA plasmid effectively inhibits Runx1 gene expression at both mRNA and protein levels in A549 cells.
• This study provides a tool for further investigation into the role of Runx1 in pulmonary adenocarcinoma.
• Targeted inhibition of Runx1 may represent a viable therapeutic approach for lung cancer.